Jamieson Wellness (JWEL) Stock Price, News & Analysis

Company Overview

Jamieson Wellness Inc is engaged in the manufacturing, distributing, and marketing of branded natural health products, including vitamins, minerals, and supplements. The company operates in two segments: The Jamieson brands and The Strategic Partners. The majority of its revenue comes from the Jamieson brand segment. Some of its brands are Jamieson, Progressive, Precision, and Iron Vegan. Geographically, most of its revenue is derived from the domestic market.

Key Stats

• Today's Range: C$33.45 to C$33.96
• 50-Day Range: C$33.13 to C$38.98
• 52-Week Range: C$31.24 to C$39.30
• Volume: 101,238 shs
• Average Volume: 85,429 shs
• Market Capitalization: C$1.40 billion
• P/E Ratio: 23.10
• Dividend Yield: 2.61%
• Price Target: C$44.00
• Consensus Rating: Buy

Jamieson Wellness Stock Analysis - MarketRank™

Jamieson Wellness scored higher than 79% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 4.1 / 5
• Analyst Rating: Buy

Consensus Rating

Jamieson Wellness has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on no strong buy ratings, 4 buy ratings, no hold ratings, and no sell ratings.

Upside Potential

Jamieson Wellness has a consensus price target of C$44.00, representing about 30.5% upside from its current price of C$33.72.

Amount of Analyst Coverage

Jamieson Wellness has only been the subject of 3 research reports in the past 90 days.

Earnings and Valuation

• Score: 1.3 / 5
• Proj. Earnings Growth: N/A

Price to Earnings Ratio vs. the Market

The P/E ratio of Jamieson Wellness is 23.10, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 38.48.

Price to Earnings Ratio vs. Sector

The P/E ratio of Jamieson Wellness is 23.10, which means that it is trading at a less expensive P/E ratio than the Consumer Defensive sector average P/E ratio of about 894.18.

Price to Book Value per Share Ratio

Jamieson Wellness has a P/B Ratio of 2.66. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

Short Interest

• Score: N/A
• Short Interest Level: N/A

Short Interest

There is no current short interest data available for JWEL.

Dividend

• Score: 1.7 / 5
• Dividend Strength: Weak

Dividend Yield

Jamieson Wellness pays a meaningful dividend of 2.74%, higher than the bottom 25% of all stocks that pay dividends.

Dividend Growth

Jamieson Wellness does not have a long track record of dividend growth.

Dividend Coverage

The dividend payout ratio of Jamieson Wellness is 60.27%. This payout ratio is at a healthy, sustainable level, below 75%.

News and Social Media

• Score: 3.6 / 5
• News Sentiment: 0.80

News Sentiment

Jamieson Wellness has a news sentiment score of 0.80. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.69 average news sentiment score of Consumer Defensive companies.

News Coverage This Week

MarketBeat has tracked 2 news articles for Jamieson Wellness this week, compared to 0 articles on an average week.

Search Interest

7 people have searched for JWEL on MarketBeat in the last 30 days. This is an increase of 250% compared to the previous 30 days.

Company Ownership

• Score: 0.6 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, Jamieson Wellness insiders have not sold or bought any company stock.

Percentage Held by Insiders

0.26% of the stock of Jamieson Wellness is held by insiders.

Percentage Held by Institutions

50.13% of the stock of Jamieson Wellness is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

JWEL Stock Analysis - Frequently Asked Questions

How have JWEL shares performed this year?

Jamieson Wellness' stock was trading at C$33.65 at the beginning of 2026. Since then, JWEL shares have increased by 0.2% and is now trading at C$33.72.

How were Jamieson Wellness' earnings last quarter?

Jamieson Wellness Inc. (TSE:JWEL) posted its quarterly earnings results on Thursday, February, 26th. The company reported $0.90 earnings per share (EPS) for the quarter. The firm earned $277.66 million during the quarter. Jamieson Wellness had a net margin of 7.60% and a trailing twelve-month return on equity of 12.97%.
Read the conference call transcript.

How do I buy shares of Jamieson Wellness?

Shares of JWEL stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.

What other stocks do shareholders of Jamieson Wellness own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Jamieson Wellness investors own include Enbridge (ENB), Canadian Natural Resources (CNQ), Crown Castle (CCI), Suncor Energy (SU), Royal Bank of Canada (RY), Algonquin Power & Utilities (AQN) and Bank of Nova Scotia (BNS).

Company Calendar

• Last Earnings: 2/26/2026
• Ex-Dividend for 3/16 Dividend: 3/06/2026
• Record date for 3/16 Dividend: 3/16/2026
• Dividend Payable: 3/16/2026
• Today: 5/07/2026

Industry, Sector and Symbol

• Stock Exchange: TSE
• Sector: Consumer Defensive
• Industry: Packaged Foods
• Sub-Industry: Retail
• Current Symbol: TSE:JWEL
• CIK: N/A
• Web: investors.jamiesonwellness.com
• Phone: +1-416-9600052
• Fax: N/A
• Employees: 240
• Year Founded: N/A

Price Target and Rating

• Average Price Target for Jamieson Wellness: C$44.00
• High Price Target: C$48.00
• Low Price Target: C$42.00
• Potential Upside/Downside: +30.5%
• Consensus Rating: Buy
• Rating Score (0-4): 3.00
• Research Coverage: 4 Analysts

Profitability

• EPS (Trailing Twelve Months): C$1.46
• Trailing P/E Ratio: 23.10
• Forward P/E Ratio: 15.73
• P/E Growth: N/A
• Net Income: C$39.83 million
• Net Margins: 7.60%
• Pretax Margin: N/A
• Return on Equity: 12.97%
• Return on Assets: 4.73%

Debt

• Debt-to-Equity Ratio: 97.24
• Current Ratio: 2.59
• Quick Ratio: 1.08

Sales & Book Value

• Annual Sales: C$822.06 million
• Price / Sales: 1.70
• Cash Flow: C$0.32 per share
• Price / Cash Flow: 103.97
• Book Value: C$12.66 per share
• Price / Book: 2.66

Miscellaneous

• Outstanding Shares: 41,477,000
• Free Float: N/A
• Market Cap: C$1.40 billion
• Optionable: Not Optionable
• Beta: 1.54